How Long Do Peptides Last? The Science of Stability, Storage, and Shelf Life
How Long Do Peptides Last? The Science of Stability, Storage, and Shelf Life
Introduction
Every research peptide has an expiration clock — but the speed of that clock depends almost entirely on how you store it. A lyophilized peptide sealed in a freezer can maintain over 95% purity for years; lyophilized peptides remain stable for extended periods under proper storage conditions, especially in powder form. The same peptide reconstituted and left on a benchtop can lose half its potency in under a week. Peptides stored in solution are less stable, typically lasting 1-4 weeks at 4°C, but some can degrade faster.
Understanding peptide stability isn’t optional for serious research — it’s fundamental. Degradation doesn’t just reduce potency; it generates breakdown products that can confound experimental results, create false positives, or introduce unexpected biological activity. Several factors—including temperature, moisture, and light—are key factors influencing peptide longevity and degradation. Proper storage is essential to maximize shelf life, and peptides in powder form, particularly lyophilized peptides, are generally more stable than those in solution. This article breaks down the science behind peptide shelf life: the chemical mechanisms driving degradation, the quantitative data from stability studies, and the evidence-based protocols that maximize useful lifespan.
Two Timelines: Lyophilized vs. Reconstituted
The single most important factor in peptide longevity is whether the compound exists as a dry powder or in solution. These represent fundamentally different stability environments. Storing peptides properly is critical for maintaining their stability and efficacy, and storage practices should be tailored to the intended use of the peptide.
Lyophilized (Freeze-Dried) Peptides
Lyophilization removes water from the peptide through sublimation, eliminating the primary reactant in hydrolytic degradation — the most common pathway of peptide breakdown. In the absence of water, the major degradation reactions (hydrolysis, deamidation, and many oxidation pathways) slow dramatically.
Stability data for lyophilized peptides:
At -20°C to -80°C: Multiple studies confirm that properly stored lyophilized peptides maintain >95% purity for 2–5+ years. The International Council for Harmonisation (ICH) Q1A(R2) guidelines use -20°C as the reference standard for long-term peptide storage, requiring minimum 12-month stability data at this condition for pharmaceutical submissions.
At 2–8°C (refrigerated): Lyophilized peptides generally remain stable for 12–24 months with minimal degradation, depending on sequence and formulation. ICH accelerated testing at 25°C/60% relative humidity over 6 months is used to model this timeframe.
At room temperature (20–25°C): Room temperature storage is suitable for an extended period of 30–60 days, during which lyophilized peptides can remain stable for a few weeks to a couple of months without significant loss of quality. However, for longer durations, freezing is recommended, as degradation increases beyond this period. Stability varies significantly by sequence, but most lyophilized peptides show measurable degradation beginning within 3–6 months. Peptides containing asparagine, methionine, or cysteine residues degrade faster due to susceptibility to deamidation and oxidation even in solid state.
At 40°C (accelerated conditions): ICH accelerated stability testing at 40°C/75% relative humidity over 6 months is standard for predicting shelf life under stress. Most peptides show significant degradation (>5% purity loss) within weeks to months at this temperature, which is why these conditions are used to predict failure points.
Reconstituted (In-Solution) Peptides
Once dissolved in aqueous solution, peptides become immediately vulnerable to hydrolysis, and degradation accelerates dramatically. Water molecules attack peptide bonds directly, and the rate increases with temperature, suboptimal pH, and microbial contamination.
Stability data for reconstituted peptides:
At 2–8°C (refrigerated): Most reconstituted peptides remain usable for approximately 1–4 weeks, though this varies substantially by sequence. A 2017 study published in BMC Pharmacology and Toxicology (Bisht et al.) found that reconstituted peptide solutions maintained approximately 89% recovery after two freeze-thaw cycles when stored at 4°C, demonstrating measurable loss even with careful handling.
At -20°C (frozen solution): Reconstituted peptides stored frozen can remain stable for 1–3 months, provided freeze-thaw cycles are minimized. Each freeze-thaw event introduces mechanical stress from ice crystal formation and creates transient concentration effects at the ice-liquid interface that accelerate aggregation.
At room temperature (20–25°C): Degradation is rapid. Studies on growth factor and signaling peptides show purity losses of 5–15% within the first 48–72 hours at room temperature. Shorter or more labile peptide sequences like BPC-157 and TB-500 may lose up to 50% potency within one week at ambient temperature, according to analytical monitoring data.
At 37°C (physiological temperature): Used in accelerated degradation studies, this temperature typically produces >20% degradation within 24–72 hours for most peptide sequences in aqueous solution.
The Chemistry of Degradation: Five Pathways
Peptide degradation isn’t a single process — it’s a collection of distinct chemical reactions, each with its own triggers and kinetics. These degradation processes are heavily influenced by the peptide sequence, as the specific arrangement and type of amino acid residues determine how susceptible a peptide is to breakdown. Sensitive residues, such as Methionine, Cysteine, and Tryptophan, are particularly prone to oxidation and other degradation pathways, making peptides containing these certain amino acids more fragile. Moisture, heat, and oxygen are key stability threats for peptides, and the inherent properties of the peptide sequence and its amino acid residues explain why certain peptides are more vulnerable and why specific storage conditions matter.
1. Hydrolysis
The most common degradation pathway. Water molecules attack peptide bonds (the amide linkages between amino acids), cleaving the chain into shorter fragments. This reaction is catalyzed by both acidic and basic conditions, which is why most peptides show optimal stability in a narrow pH window of 6.5–7.5.
Hydrolysis is temperature-dependent and follows Arrhenius kinetics — meaning its rate approximately doubles for every 10°C increase in temperature. This relationship, known as the Q10 rule, is the foundational principle behind pharmaceutical accelerated stability testing.
Certain sequences are particularly vulnerable. Aspartyl residues (Asp-Pro and Asp-Gly bonds) undergo hydrolysis up to 100 times faster than average peptide bonds. This is relevant for peptides containing aspartic acid, including BPC-157 (Body Protection Compound), which requires careful pH management to maintain structural integrity.
2. Deamidation
Asparagine (Asn) and glutamine (Gln) residues spontaneously lose their amide groups, converting to aspartic acid and glutamic acid respectively. This introduces a negative charge that alters the peptide’s isoelectric point, binding affinity, and potentially its biological activity.
Deamidation rates are sequence-dependent. Asn-Gly sequences deamidate fastest, with half-lives as short as 1–4 days in solution at physiological pH and temperature. Asn-Ser and Asn-His sequences are also vulnerable. A landmark 1990 study in Pharmaceutical Research (Patel & Borchardt) characterized deamidation kinetics for adrenocorticotropic hormone, establishing that this pathway accounts for a major share of peptide degradation in neutral aqueous conditions.
In the solid (lyophilized) state, deamidation still occurs but at dramatically reduced rates — typically 100–1,000 times slower than in solution — because the reaction requires water as a reactant.
3. Oxidation
Peptides containing methionine (Met), cysteine (Cys), tryptophan (Trp), tryptophan residues, or tyrosine (Tyr) are susceptible to oxidative degradation, with tryptophan residues being particularly prone to oxidation. The most common products are methionine sulfoxide and cysteine disulfide bonds (or sulfenic acid intermediates).
Oxidation can be triggered by: – Dissolved oxygen in reconstitution solutions – Metal ion contaminants (iron, copper) that catalyze free radical formation – Light exposure, particularly UV radiation and bright light, which generates reactive oxygen species and accelerates peptide degradation – Peroxide contaminants in excipients or storage materials
Storing peptides in an oxygen free environment helps prevent oxidation, especially for peptides containing sensitive residues like methionine, cysteine, and tryptophan. Peptides are also light-sensitive and should be stored in dark containers or wrapped in foil to prevent photochemical degradation.
Studies using HPLC monitoring have shown that Met-containing peptides stored in aerated solutions at 25°C can show 5–10% oxidation within 1–2 weeks, with the rate increasing in the presence of trace metals. This is why chelating agents like EDTA and antioxidants like methionine (as a sacrificial scavenger) are used in pharmaceutical peptide formulations.
4. Aggregation
Peptides can self-associate through hydrophobic interactions, forming dimers, oligomers, or insoluble aggregates. Aggregation reduces the concentration of active monomer and can generate immunogenic structures in biological systems.
Freeze-thaw cycles are a major driver of aggregation. During freezing, peptides concentrate at the ice-liquid interface, promoting intermolecular interactions. The 2016 recommendations from Hoofnagle et al. in Clinical Chemistry — a comprehensive guide developed by researchers at the University of Washington, Fred Hutchinson Cancer Research Center, and the Broad Institute — specifically emphasize minimizing freeze-thaw cycles and using proper aliquoting protocols to prevent aggregation-driven losses.
5. Racemization
Under certain pH and temperature conditions, L-amino acids in the peptide chain can convert to their D-enantiomers. While typically slower than other degradation pathways, racemization permanently alters the peptide’s three-dimensional structure and can abolish receptor binding activity.
Temperature: The Master Variable
If there’s one principle that governs peptide stability, it’s the Arrhenius equation:
k = A × e^(-Ea/RT)
Where k is the degradation rate constant, Ea is the activation energy, R is the gas constant, and T is temperature in Kelvin. This equation predicts that chemical reaction rates increase exponentially with temperature. Refrigeration slows degradation by reducing the kinetic energy of molecules, which helps preserve peptide stability. However, temperature fluctuations can compromise peptide stability, so maintaining consistent, lower temperatures is essential for maximum stability. Peptides last in the fridge for a limited time, and lower temperatures (such as -20°C or -80°C) are preferable for long-term storage. When storing peptides in the refrigerator, they should be kept in airtight containers with minimal headspace to reduce oxidation and moisture exposure.
The Q10 Rule in Practice
For most peptide degradation reactions, the activation energy falls in the range of 60–120 kJ/mol, which translates to the practical Q10 rule: every 10°C increase in temperature roughly doubles the rate of degradation.
This has profound implications for storage:
Storage Temperature | Relative Degradation Rate | Practical Impact |
|---|---|---|
-80°C | ~1x (baseline) | Gold standard for long-term storage |
-20°C | ~2–4x baseline | Standard long-term storage; years of stability |
4°C (refrigerator) | ~8–16x baseline | Weeks to months for reconstituted; 1–2 years lyophilized |
25°C (room temp) | ~64–256x baseline | Days to weeks reconstituted; months lyophilized |
37°C (body temp) | ~250–1,000x baseline | Hours to days; used for accelerated testing only |
40°C (ICH accelerated) | ~500–2,000x baseline | ICH standard stress condition |
What This Means for Shipping
A peptide shipped at ambient temperature during summer (potentially 30–40°C inside a delivery vehicle) for 2–3 days experiences the equivalent of weeks to months of degradation at -20°C. This is why cold chain shipping with ice packs or dry ice isn’t a luxury — it’s a necessity for maintaining the integrity of the product that was verified by quality assurance at the time of manufacture.
Moisture: The Silent Destroyer
Even lyophilized peptides aren’t immune to environmental damage. Hygroscopic absorption of atmospheric moisture can reintroduce water into the solid matrix, reactivating hydrolytic degradation pathways. To prevent condensation and degradation, peptides should be handled in a way that minimizes exposure to air and moisture, and stored in sealed containers or tightly sealed vials.
Studies on solid-state peptide stability show that moisture content above 2–3% by weight significantly accelerates degradation in lyophilized cakes. This is why pharmaceutical-grade peptides are:
Sealed under vacuum or inert gas (nitrogen or argon) to exclude moisture and oxygen
Stored with desiccant packets in secondary packaging
Packaged in butyl rubber stoppered vials that minimize moisture permeation
Placed in airtight containers with minimal headspace to prevent oxidation and moisture ingress
Opening a vial repeatedly — especially in humid environments — introduces moisture each time. For research applications where only partial vial contents are needed, the best practice is to reconstitute the entire vial, aliquot into single-use portions, and freeze the aliquots immediately. Lyophilized peptides can remain stable for several years when stored in a cold, dry, and dark environment, particularly at -80°C.
pH: The Stability Sweet Spot
Most peptides exhibit optimal stability in a narrow pH range of 6.0–7.5. Deviation in either direction accelerates specific degradation pathways:
pH < 5: Acid-catalyzed hydrolysis accelerates. Asp-Pro bonds are particularly vulnerable to acid cleavage.
pH 5–6: Deamidation rate increases for Asn residues through a cyclic imide intermediate.
pH > 8: Base-catalyzed hydrolysis and β-elimination reactions increase. Cysteine residues undergo disulfide scrambling.
Bacteriostatic water (BAC water), commonly used for peptide reconstitution, typically has a pH of 5.0–7.0. The benzyl alcohol preservative (0.9%) provides antimicrobial protection but doesn’t buffer pH. For research applications requiring precise pH control, phosphate-buffered saline (PBS) at pH 7.4 or acetate buffers at pH 5.0 provide more consistent environments.
Light: The Overlooked Factor
Photodegradation affects peptides containing aromatic amino acids — particularly tryptophan (Trp) and tyrosine (Tyr). UV radiation (280–320 nm) generates reactive oxygen species that attack these residues, producing oxidized derivatives and cross-linked products.
ICH Q1B photostability testing guidelines require exposure to a minimum of 1.2 million lux-hours of visible light and 200 watt-hours per square meter of UV light. Peptides failing these tests require light-protected packaging.
Practical impact: Leaving reconstituted peptide vials on a lab bench under fluorescent lighting for extended periods can contribute to measurable degradation. Amber glass vials or aluminum foil wrapping provide effective protection.
Reconstitution Solvent Matters
The choice of reconstitution solvent significantly impacts post-dissolution stability: using sterile techniques during reconstitution is essential to prevent bacterial contamination and maintain peptide stability. Sterile buffers and equipment help avoid introducing microbes or particulates that could degrade the peptide or shorten its usable life.
For most peptides, sterile water or bacteriostatic water is preferred, but certain additives, such as trehalose, can enhance stability in peptide powder formulations by protecting against oxidation and degradation during storage. Avoiding repeated freeze-thaw cycles and ensuring proper sealing also help prevent bacterial contamination and maintain peptide integrity.
Peptides in solution are generally less stable than in powder form, as water can accelerate hydrolysis and support microbial growth. Peptides in powder form, particularly lyophilized peptides, are generally more stable than those in solution, as the absence of water minimizes hydrolysis and microbial growth.
Bacteriostatic Water (BAC Water)
Contains 0.9% benzyl alcohol as preservative
Prevents microbial growth that would otherwise accelerate degradation
Standard choice for multi-use vials that will be accessed over several days
Reconstituted peptides in BAC water at 2–8°C: typically stable 2–4 weeks
Sterile Water
No preservative — microbe-free only at the moment of opening
Better suited for single-use reconstitution
Slightly longer chemical stability (no benzyl alcohol interaction) but shorter practical stability due to contamination risk
Reconstituted peptides in sterile water at 2–8°C: typically stable 1–2 weeks before microbial contamination becomes a concern
Acetic Acid (0.1%)
Used for hydrophobic or poorly soluble peptides
The mildly acidic pH (3.0–3.5) can improve solubility but may accelerate certain degradation pathways
Not ideal for long-term storage due to acid-catalyzed hydrolysis
DMSO
Used for highly hydrophobic peptides that won’t dissolve in aqueous solutions
Provides excellent chemical stability but is not compatible with all biological assays
Peptides in DMSO at -20°C can remain stable for months to years
Freeze-Thaw: Quantifying the Damage
Repeated freezing and thawing is one of the most common — and most preventable — causes of peptide degradation in research settings. Repeated freeze-thaw cycles can accelerate peptide degradation and cause structural damage to peptides. To minimize this risk, it is advisable to aliquot peptide solutions into single-use doses, which helps prevent repeated freeze-thaw cycles and the associated damage.
The Mechanism
During freezing, ice crystal formation creates two damaging effects:
Cryo-concentration: As water freezes, dissolved peptides and salts concentrate in the remaining liquid phase. This can push local concentrations high enough to promote aggregation and precipitation.
Ice-liquid interface adsorption: Peptides accumulate at the surface of growing ice crystals, where mechanical stress and surface denaturation occur.
The Data
The 2016 Hoofnagle et al. study in Clinical Chemistry (a collaborative effort across multiple major research institutions) directly measured freeze-thaw effects on peptide signal intensity. Their findings showed:
Peptide mixtures stored continuously at 4°C maintained higher signal intensity than those subjected to freeze-thaw cycles
The recommendation is to aliquot reconstituted peptides into single-use portions before initial freezing
A 2017 study (Bisht et al., BMC Pharmacology and Toxicology) quantified the impact: after just two freeze-thaw cycles, peptide recovery dropped to approximately 89% — an 11% loss from a preventable handling error
Best Practice: Aliquoting
The evidence-based solution is straightforward:
Reconstitute the entire vial at once
Immediately divide into single-use aliquots (microcentrifuge tubes)
Flash-freeze aliquots in liquid nitrogen or a -80°C freezer
Thaw only the aliquot needed for each use — never refreeze
This protocol virtually eliminates freeze-thaw damage and is universally recommended in the peptide handling literature.
Sequence-Specific Stability: Not All Peptides Are Equal
Peptide stability varies enormously based on amino acid composition and peptide sequence. The inherent properties of the peptide sequence, including the presence of certain amino acid residues, play a critical role in determining susceptibility to degradation. Certain amino acids—such as Methionine (Met), Cysteine (Cys), and Tryptophan (Trp)—are particularly prone to oxidation and degradation, making peptides containing these residues more sensitive to environmental factors. Moisture, heat, and oxygen are key stability threats for peptides, especially those with these specific amino acids. Some general principles from the research literature:
More Stable Peptides
Cyclic peptides — the ring structure protects against exopeptidase cleavage and reduces conformational flexibility that promotes aggregation
Short peptides (< 10 amino acids) — fewer susceptible residues, fewer aggregation-prone regions
Peptides rich in Ala, Val, Leu, Ile — hydrophobic residues without reactive side chains
Less Stable Peptides
Asp-containing peptides — prone to aspartimide formation and isomerization (relevant to BPC-157)
Asn-Gly sequences — fastest deamidation rates of any dipeptide motif
Met-containing peptides — methionine oxidation to sulfoxide
Cys-containing peptides — disulfide bond scrambling, oxidation to sulfenic/sulfinic acid
Long sequences (> 30 amino acids) — more opportunities for degradation and aggregation; relevant to peptides like CJC-1295 and Semaglutide
Practical Examples
BPC-157 (15 amino acids, contains Asp): Requires careful pH management; reconstituted stability at 4°C is approximately 1–2 weeks before significant degradation is measurable
Semaglutide (31 amino acids, fatty acid conjugated): The C18 fatty acid sidechain improves albumin binding and in vivo half-life but doesn’t prevent chemical degradation in storage; lyophilized stability at -20°C exceeds 2 years
GHK-Cu (3 amino acids, copper complex): Short sequence confers reasonable stability, but the copper coordination is pH-sensitive; reconstituted stability at 4°C approximately 2–4 weeks
TB-500 / Thymosin Beta-4 (43 amino acids): Longer sequence with multiple degradation-susceptible residues; reconstituted stability at room temperature may be as short as 3–7 days
How to Detect Degraded Peptides
Degradation isn’t always visible to the naked eye, but several indicators can alert researchers to compromised material:
Visual Signs
Cloudiness or turbidity in reconstituted solution (indicates aggregation or precipitation)
Color change from clear/colorless to yellow or brown (indicates oxidation)
Failure to dissolve completely during reconstitution (possible moisture-induced solid-state degradation)
Unusual viscosity (indicates high-molecular-weight aggregate formation)
Analytical Methods
HPLC (High-Performance Liquid Chromatography): The gold standard. Compares the chromatographic profile of the sample against the original quality assurance. New peaks indicate degradation products; reduced main peak area indicates potency loss.
Mass Spectrometry: Detects molecular weight changes from deamidation (+1 Da), oxidation (+16 Da for Met-sulfoxide), and hydrolysis (fragmentation).
UV Spectroscopy: Changes in absorbance at 214 nm or 280 nm can indicate degradation or aggregation.
Functional Indicators
Inconsistent experimental results where the same protocol yields different outcomes across time
Reduced biological activity in cell-based or binding assays compared to fresh peptide
Higher-than-expected variability in dose-response curves
Evidence-Based Storage Protocol
Based on the accumulated data from pharmaceutical stability studies, ICH guidelines, and peptide research, here is the optimal storage protocol:
Peptides stored properly—using appropriate temperature, humidity, and packaging—can significantly extend their shelf life and maintain stability. For short term storage, peptides may be kept at room temperature or in a stabilized environment, but this period should be minimized to avoid degradation. Always protect peptides from light, minimize freeze-thaw cycles, and use suitable containers to further maintain stability and avoid degradation.
Lyophilized peptides can remain stable for several years when stored at -20°C, and even longer at -80°C, due to the removal of water which minimizes degradation reactions.
For Lyophilized (Powder) Peptides
Parameter | Recommendation | Rationale |
|---|---|---|
Temperature | -20°C (standard) or -80°C (optimal) | Arrhenius kinetics; minimizes all degradation rates |
Atmosphere | Sealed under vacuum, nitrogen, or argon | Prevents oxidation and moisture absorption |
Light | Amber vial or foil-wrapped | Prevents photodegradation of Trp/Tyr residues |
Moisture | Desiccant in secondary container | Maintains low moisture content in lyophilized cake |
Expected stability | 2–5+ years at -20°C | Based on ICH long-term stability data and published studies |
For Reconstituted (Solution) Peptides
Parameter | Recommendation | Rationale |
|---|---|---|
Solvent | Bacteriostatic water for multi-use; sterile water for single-use | BAC water prevents microbial contamination |
Temperature | 2–8°C for active use; -20°C for aliquots | Minimizes hydrolysis and deamidation rates |
Aliquoting | Divide into single-use portions immediately after reconstitution | Eliminates freeze-thaw damage (prevents ~11% loss per cycle) |
Light | Amber vial or foil-wrapped | Prevents photodegradation |
Handling | Minimize time at room temperature; return to refrigerator immediately | Every hour at 25°C = approximately 4–8 hours of degradation at 4°C |
Expected stability | Reconstituted peptides typically remain effective for a few weeks (2–4 weeks) when refrigerated at 2–8°C, with some lasting up to 90 days depending on the compound; 1–3 months at -20°C (single freeze) | Based on analytical monitoring data and published studies; stability varies by peptide type and storage conditions |
The IronPeak Standard
At IronPeak Peptides, we understand that a quality assurance is only meaningful if the compound maintains its verified purity from our facility to your laboratory. That’s why our quality protocols address the full stability chain:
Third-party HPLC and mass spectrometry verification confirms purity at the time of manufacture
Lyophilized formulation removes water and maximizes shelf life
Sealed under controlled atmosphere to minimize oxidation and moisture ingress
Cold chain shipping to maintain compound integrity during transit
We provide quality assurance with complete chromatographic data so researchers can verify peptide identity and purity — and establish a baseline for their own stability monitoring throughout experimental timelines.
Key Takeaways
Lyophilized peptides stored at -20°C can last 2–5+ years with >95% purity retention. This is the gold standard.
Reconstituted peptides are on a much shorter clock — typically 2–4 weeks refrigerated, days at room temperature.
Temperature is the dominant variable. Every 10°C increase roughly doubles degradation rate. There are no shortcuts here.
Freeze-thaw cycles cause measurable damage — approximately 11% loss after just two cycles. Aliquot immediately after reconstitution.
Degradation pathways are sequence-specific. Asp-containing peptides (like BPC-157) hydrolyze faster; Met-containing peptides oxidize faster; Asn-Gly sequences deamidate fastest.
Storage is not passive. Temperature, moisture, light, pH, and oxygen all actively degrade peptides. Evidence-based protocols address each factor.
When in doubt, check the data. HPLC analysis against the original quality assurance is the definitive way to confirm peptide integrity.
References
ICH Q1A(R2). Stability Testing of New Drug Substances and Products. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, 2003.
Hoofnagle AN, Whiteaker JR, Carr SA, et al. “Recommendations for the generation, quantification, storage and handling of peptides used for mass spectrometry-based assays.” Clinical Chemistry. 2016;62(1):48–69.
Bisht R, et al. “Development of a novel stability indicating RP-HPLC method for peptide quantification.” BMC Pharmacology and Toxicology. 2017;19(1):15.
Patel K, Borchardt RT. “Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone.” Pharmaceutical Research. 1990;7(7):703–711.
Patel K, Borchardt RT. “Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide.” Pharmaceutical Research. 1990;7(8):787–793.
González-González O, et al. “Drug Stability: ICH versus Accelerated Predictive Stability Studies.” Pharmaceutics. 2022;14(11):2324.
Manning MC, Chou DK, Murphy BM, et al. “Stability of protein pharmaceuticals: An update.” Pharmaceutical Research. 2010;27(4):544–575.
ICH Q1B. Stability Testing: Photostability Testing of New Drug Substances and Products. International Council for Harmonisation, 1996.
Lai MC, Topp EM. “Solid-state chemical stability of proteins and peptides.” Journal of Pharmaceutical Sciences. 1999;88(5):489–500.
Maurer J, et al. “Tutorial review for peptide assays: An ounce of pre-analytics is worth a pound of cure.” Talanta. 2024;266:125010.
All peptides referenced in this article are intended for laboratory research use only. IronPeak Peptides supplies research-grade compounds for scientific investigation. Not for human consumption.
Related Research
→ CJC-1295 vs Ipamorelin: Complete Research Comparison Guide
→ GHRP-6: Complete Research Guide — Growth Hormone Releasing Hexapeptide Mechanisms & Evidence
→ Complete Guide to Peptide Reconstitution for Laboratory Research
🔬 Explore Research Peptides
- Adamax 5mg — $59.00
- Selank + Semax 10mg/10mg (20mg) — $89.00
- BPC-157/TB-500 Blend 10mg/10mg (20mg) — $110.00
- TB-500 10mg — $69.99







